Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elevance Health's Ending Cash Position for the quarter that ended in Jun. 2026 was $10,232 Mil.
Elevance Health's quarterly Ending Cash Position
increased
from Dec. 2025 ($9,491 Mil) to Mar. 2026 ($9,657 Mil) and
increased
from Mar. 2026 ($9,657 Mil) to Jun. 2026 ($10,232 Mil).
Elevance Health's annual Ending Cash Position
increased
from Dec. 2023 ($6,526 Mil) to Dec. 2024 ($8,288 Mil) and
increased
from Dec. 2024 ($8,288 Mil) to Dec. 2025 ($9,491 Mil).
Elevance Health Ending Cash Position Related Terms
Elevance Health Ending Cash Position Historical Data
* Premium members only.
The historical data trend for Elevance Health's Ending Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
Elevance Health's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as
What does a Ending Cash Position of $10,232 Mil mean?
Elevance Health (ELV) has a Ending Cash Position of $10,232 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Elevance Health and its competitors.
Is Elevance Health's Ending Cash Position too high?
Elevance Health's current Ending Cash Position is $10,232 Mil. Overall, Elevance Health has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Ending Cash Position compare to CI and HUM?
Elevance Health's Ending Cash Position of $10,232 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Plans company?
A good Ending Cash Position depends on the Healthcare Plans industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Elevance Health and its competitors. Elevance Health's current Ending Cash Position is $10,232 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is $489.98, compared to a current price of $391.16 — trading 20.2% below its estimated fair value. The current Ending Cash Position is $10,232 Mil. Elevance Health's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Elevance Health (ELV), the current Ending Cash Position is $10,232 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of $391.16 is trading 20.2% below its estimated GF Value™ of $489.98.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for ELV:
Ending Cash Position: $10,232 Mil
GF Value™: $489.98 vs. price of $391.16 (20.2% below fair value)
No single metric tells the full story. See the ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
90GF Score
Get the complete analysis for ELV
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELV has been successfully added to your 
